Editorial
World J Virol
10(2):30-33.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.30
Abstract (730)
|
Core Tip (704)
|
Full Article (HTML) (1849)
|
Figures (1-4) (596)
|
Full Article (PDF)-1129K (290)
|
Audio-540K (10)
|
Peer-Review Report-149K (134)
|
Answering Reviewers-64K (117)
|
Received: 01/14/2021
|
Revised: 01/30/2021
|
Accepted: 02/05/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7898)
|
Similar Articles (1)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
World J Virol
10(2):34-52.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.34
Abstract (1335)
|
Core Tip (863)
|
Full Article (HTML) (10488)
|
Tables (1-3) (341)
|
Full Article (PDF)-950K (960)
|
Audio-1256K (29)
|
Peer-Review Report-242K (261)
|
Answering Reviewers-119K (279)
|
Received: 12/29/2020
|
Revised: 01/23/2021
|
Accepted: 03/12/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (19452)
|
Similar Articles (698)
|
Timeline of Article Publication (1)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review
World J Virol
10(2):53-61.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.53
Abstract (731)
|
Core Tip (739)
|
Full Article (HTML) (2531)
|
Tables (1-3) (358)
|
Full Article (PDF)-837K (245)
|
Audio-1070K (27)
|
Peer-Review Report-217K (138)
|
Answering Reviewers-69K (144)
|
Received: 12/12/2020
|
Revised: 01/28/2021
|
Accepted: 03/08/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8116)
|
Similar Articles (687)
|
Timeline of Article Publication (9)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza
World J Virol
10(2):62-68.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.62
Abstract (727)
|
Core Tip (712)
|
Full Article (HTML) (2680)
|
Figures (1-2) (363)
|
Tables (1-3) (297)
|
Full Article (PDF)-4630K (327)
|
Audio-444K (3)
|
Peer-Review Report-202K (152)
|
Answering Reviewers-117K (172)
|
Received: 12/18/2020
|
Revised: 01/16/2021
|
Accepted: 02/20/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (9269)
|
Similar Articles (788)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries
World J Virol
10(2):69-85.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.69
Abstract (799)
|
Core Tip (741)
|
Article Highlights (803)
|
Full Article (HTML) (3231)
|
Figures (1-8) (383)
|
Tables (1-1) (367)
|
Full Article (PDF)-10779K (274)
|
Audio-581K (24)
|
Peer-Review Report-162K (179)
|
Answering Reviewers-206K (180)
|
Received: 11/04/2020
|
Revised: 12/22/2020
|
Accepted: 01/08/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (10995)
|
Similar Articles (1)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open